Alex Miras is currently a Senior Clinical Lecturer and Consultant in Endocrinology at Imperial College London and interested in the mechanisms through which lifestyle interventions, pharmacotherapy, bariatric surgery and medical devices improve weight, metabolic control and diabetes-related microvascular complications.
et al., 2023, Tripeptide gut hormone infusion does not alter food preferences or sweet taste function in volunteers with obesity and prediabetes/diabetes but promotes restraint eating: a secondary analysis of a randomized single-blind placebo-controlled study, Diabetes, Obesity and Metabolism: a Journal of Pharmacology and Therapeutics, Vol:25, ISSN:1462-8902, Pages:1731-1739
et al., 2023, Clinical characteristics of patients undergoing primary bariatric surgery in the United Kingdom based on the National Bariatric Surgery Registry, Clinical Obesity, Vol:13, ISSN:1758-8103
et al., 2023, Bariatric-metabolic surgery for NHS patients with type 2 diabetes in the United Kingdom National Bariatric Surgery Registry, Diabetic Medicine, Vol:40, ISSN:0742-3071
et al., 2023, The implications of defining obesity as a disease: a report from the Association for the Study of Obesity 2021 annual conference, Eclinicalmedicine, Vol:58, ISSN:2589-5370
et al., 2023, Diagnosis and management of parathyroid carcinoma: a state-of-the-art review, Endocrine-related Cancer, Vol:30, ISSN:1351-0088